10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001144204-16-133295`
Period End Date	20160930
Filing Date	20161110
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	enzn-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 50 Income Statement 52 Cash Flow Statement 26

Balance Sheet 50 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$20.25M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$12.90M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$107.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$234.00K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$13.13M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.78M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Deferred tax assets, net	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$11.11M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Deferred tax assets, net	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$8.61M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Total assets	`Assets`	$22.89M	USD	Point-in-time
Total assets	`Assets`	$21.74M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$90.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	-	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$163.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$205.00K	USD	Point-in-time
Accrued lease termination costs	`AccruedLeaseTerminationCostsCurrent`	$4.51M	USD	Point-in-time
Accrued lease termination costs	`AccruedLeaseTerminationCostsCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$163.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.80M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at September 30, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $0.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at September 30, 2016 and December 31, 2015	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at September 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$441.00K	USD	Point-in-time
Common stock - $0.01 par value, authorized 170,000,000 shares; issued and outstanding 44,214,603 shares at September 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$441.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$96.91M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$96.91M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-75.78M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.27M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$21.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$18.09M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$22.89M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$21.74M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$1.97M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$3.77M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$7.46M	USD	3 Qtrs
Royalties	`RoyaltyRevenue`	$14.07M	USD	3 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$21.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$73.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$224.00K	USD	3 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$63.00K	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$14.29M	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$7.52M	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$1.99M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$3.84M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.53M	USD	3 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$213.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$376.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$1.31M	USD	3 Qtrs
Lease termination costs	`GainLossOnContractTermination`	-	USD	3 Qtrs
Lease termination costs	`GainLossOnContractTermination`	$-4.55M	USD	1 Quarter
Lease termination costs	`GainLossOnContractTermination`	-	USD	1 Quarter
Lease termination costs	`GainLossOnContractTermination`	$-4.55M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$4.76M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.86M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.53M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$376.00K	USD	1 Quarter
Operating income (loss) and income (loss) before income tax expense (benefit)	`OperatingIncomeLoss`	$8.43M	USD	3 Qtrs
Operating income (loss) and income (loss) before income tax expense (benefit)	`OperatingIncomeLoss`	$5.99M	USD	3 Qtrs
Operating income (loss) and income (loss) before income tax expense (benefit)	`OperatingIncomeLoss`	$1.61M	USD	1 Quarter
Operating income (loss) and income (loss) before income tax expense (benefit)	`OperatingIncomeLoss`	$-926.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-712.00K	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$674.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$888.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$2.50M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$3.49M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$936.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$9.14M	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.04	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.02	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.21	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.08	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.04	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.08	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.02	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.21	USD	3 Qtrs
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.18M	shares	1 Quarter
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.18M	shares	3 Qtrs
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.21M	shares	1 Quarter
Weighted-average shares - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	44.21M	shares	3 Qtrs
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.21M	shares	3 Qtrs
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.21M	shares	3 Qtrs
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.18M	shares	1 Quarter
Weighted-average shares - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	44.21M	shares	1 Quarter

Cash Flow Statement 26 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$-1.81M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.49M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$936.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$9.14M	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$2.50M	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-848.00K	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$4.76M	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-3.92M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$12.21M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$1.22M	USD	3 Qtrs
Withholding taxes - stock based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$6.00K	USD	3 Qtrs
Withholding taxes - stock based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	3 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	-	USD	3 Qtrs
Common stock dividend	`PaymentsOfDividendsCommonStock`	$26.51M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-26.51M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	-	USD	3 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-14.31M	USD	3 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.22M	USD	3 Qtrs
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$20.25M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.90M	USD	Point-in-time
Cash at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$20.25M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$34.56M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.90M	USD	Point-in-time
Cash at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.67M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.